Extract notice to the Minister

Sandoz Tofacitinib

Common name / Subject : tofacitinib (citrate de)
Name of the manufacturer : Sandoz
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription- Avec conditions

Minister's decisions
Inscrire aux listes des
médicaments - Médicament
d'exception

Evaluation published on November 06, 2025

Subscribe to our newsletter now

Subscription